171 related articles for article (PubMed ID: 8843971)
1. Serum prostate-specific antigen in healthy Chinese men: establishment of age-specific reference ranges.
Lin WY; Gu CJ; Kao CH; Changlai SP; Wang SJ
Neoplasma; 1996; 43(2):103-5. PubMed ID: 8843971
[TBL] [Abstract][Full Text] [Related]
2. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men.
Khezri AA; Shirazi M; Ayatollahi SM; Lotfi M; Askarian M; Ariafar A; Afrasiabi MA
Iran J Immunol; 2009 Mar; 6(1):40-8. PubMed ID: 19293477
[TBL] [Abstract][Full Text] [Related]
3. Age-related free PSA, total PSA and free PSA/total PSA ratios: establishment of reference ranges in Chinese males.
Kao CH
Anticancer Res; 1997; 17(2B):1361-5. PubMed ID: 9137499
[TBL] [Abstract][Full Text] [Related]
4. Prostate specific antigen reference ranges in Saudi men.
Kamal BA; Ali GA; Taha SA
Saudi Med J; 2003 Jun; 24(6):665-8. PubMed ID: 12847600
[TBL] [Abstract][Full Text] [Related]
5. Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer.
Chun FK; Perrotte P; Briganti A; Benayoun S; Lebeau T; Ramirez A; Lewinshtein DJ; Valiquette L; Guay JP; Karakiewicz PI
BJU Int; 2006 Jul; 98(1):50-3. PubMed ID: 16831142
[TBL] [Abstract][Full Text] [Related]
6. Age-specific reference levels of serum prostate-specific antigen and prostate volume in healthy Arab men.
Kehinde EO; Mojiminiyi OA; Sheikh M; Al-Awadi KA; Daar AS; Al-Hunayan A; Anim JT; Al-Sumait AA
BJU Int; 2005 Aug; 96(3):308-12. PubMed ID: 16042719
[TBL] [Abstract][Full Text] [Related]
7. Percent free PSA as an additional measure in a prostate cancer screen.
Miele ME
Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
[TBL] [Abstract][Full Text] [Related]
8. [Influence of age on serum prostate specific antigen concentration].
Wang Z; Liu D; Zhau L
Zhonghua Wai Ke Za Zhi; 1996 Jun; 34(6):368-9. PubMed ID: 9594181
[TBL] [Abstract][Full Text] [Related]
9. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
Haese A; Dworschack RT; Partin AW
J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
[TBL] [Abstract][Full Text] [Related]
10. Age-specific reference ranges for prostate-specific antigen (PSA) in Jordanian patients.
Battikhi MN
Prostate Cancer Prostatic Dis; 2003; 6(3):256-60. PubMed ID: 12970732
[TBL] [Abstract][Full Text] [Related]
11. Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran.
Hosseini SY; Moharramzadeh M; Ghadian AR; Hooshyar H; Lashay AR; Safarinejad MR
Int J Urol; 2007 May; 14(5):406-11. PubMed ID: 17511722
[TBL] [Abstract][Full Text] [Related]
12. [Age specific reference ranges and clinical trial for complexed prostate specific antigen (cPSA)].
Haga R; Shimomura H; Ishizakaa Y; Yamakado M; Yamaguchi K; Tominaga T
Rinsho Byori; 2006 Jan; 54(1):22-6. PubMed ID: 16499225
[TBL] [Abstract][Full Text] [Related]
13. Are age-specific reference ranges for prostate specific antigen population specific?
Wolff JM; Brehmer B; Borchers H; Rohde D; Jakse G
Anticancer Res; 2000; 20(6D):4981-3. PubMed ID: 11326652
[TBL] [Abstract][Full Text] [Related]
14. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
Men S; Cakar B; Conkbayir I; Hekimoglu B
J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
[TBL] [Abstract][Full Text] [Related]
15. Detection rate of prostate cancer according to prostate-specific antigen and digital rectal examination in Korean men: a nationwide multicenter study.
Seo HK; Chung MK; Ryu SB; Lee KH;
Urology; 2007 Dec; 70(6):1109-12. PubMed ID: 18158028
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
[TBL] [Abstract][Full Text] [Related]
17. Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system.
Vashi AR; Wojno KJ; Henricks W; England BA; Vessella RL; Lange PH; Wright GL; Schellhammer PF; Weigand RA; Olson RM; Dowell BL; Borden KK; Oesterling JE
Urology; 1997 Jan; 49(1):19-27. PubMed ID: 9000179
[TBL] [Abstract][Full Text] [Related]
18. Prostate carcinoma among men with human immunodeficiency virus infection.
Crum NF; Spencer CR; Amling CL
Cancer; 2004 Jul; 101(2):294-9. PubMed ID: 15241826
[TBL] [Abstract][Full Text] [Related]
19. Prospective longitudinal evaluation of men with initial prostate specific antigen levels of 4.0 ng./ml. or less.
Harris CH; Dalkin BL; Martin E; Marx PC; Ahmann FR
J Urol; 1997 May; 157(5):1740-3. PubMed ID: 9112517
[TBL] [Abstract][Full Text] [Related]
20. Biopsy indication--a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c disease.
Freedland SJ; Mangold LA; Epstein JI; Partin AW
Urology; 2004 May; 63(5):887-91. PubMed ID: 15134972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
